Transient transfection of human embryonic kidney cells (HEK 293) enables the rapid and affordable lab-scale production of recombinant proteins. In this chapter protocols for the expression and purification of both secreted and intracellular proteins using transient expression in HEK 293 cells are described.
Introduction
High quality, pure proteins are important reagents for a wide variety of applications such as biochemical assays, protein-based therapeutics and protein crystallography. E. coli remains the most commonly used expression host for producing recombinant proteins for research purposes, for example structural studies, due to its ease of use and relatively low cost. However, production of recombinant proteins in high yield from E. coli can be challenging due to low expression levels and poor solubility. This is particularly the case for mammalian proteins.
Although expression of many human intracellular proteins has been tried in E. coli, about 65 % are either not expressed or expressed insolubly (1) . These problems may be overcome by using mammalian cells for protein production as these express the necessary chaperones for correct folding and contain the machinery for adding post-translational modifications (PTMs).
Mammalian cells also contain small molecules and cofactors which may be required for protein expression or complex formation. In contrast to their use with secreted proteins, mammalian cells have not been used routinely for the production of intracellular proteins due to the relatively low levels of expression compared with insect or bacterial systems. However, by using highly selective purification methods, e.g.
FLAG® tag (7) or Halo® tag (8) , it is possible to achieve useful yields of intracellular proteins.
Again, transient expression in HEK 293 cells offers a way of rapidly assessing the protein yield and quality. Subsequent production of stable cell lines, typically by co-selection, may be required to sustain and improve the production levels of a particular product.
In this chapter, protocols for the production of both secreted and intracellular proteins by transient transfection of HEK 293 cells are described. The methods are exemplified by reference to the production of the secreted protein, human serum amyloid P component (SAP) and the intracellular proteins, human brain specific protein kinase C isoform protein kinase M zeta (PKMζ) and human histone deacetylase 3 (HDAC3) in complex with its activation domain from the SMRT co-repressor (SMRT-DAD).
SAP is a plasma glycoprotein (9) which participates in the innate human immune system but also plays a role in the molecular pathology of diseases such as amyloidosis and amyloid associated diseases such as Alzheimer's and Type II diabetes (10) . SAP is of increasing clinical relevance 4 as radio-labelled SAP is used for identifying sites of amyloid deposition (11) , whilst drug development programs attempting to deplete serum levels (for treatment of amyloidosis) and also administer protein (for treatment of fibrosis) are currently underway (12) (13) . SAP contains an N-glycan and a disulphide bridge and is representative of proteins with these modifications.
PKMζ is a neuron-specific isoform of atypical protein kinase C (aPKC) that lacks the normal Nterminal regulatory region and therefore comprises just a kinase catalytic domain (14) . In vivo phosphorylation of PKMζ by PDK1 converts PKMζ into a conformation with high constitutive activity (15) . Although there is controversy as to the extent and nature of its role, PKMζ has been implicated in both memory (16) and pain (17) . PKMζ contains 5 cysteines (with the potential for disulphide bridge formation) and is activated via phosphorylation.
HDAC3 is a class I histone deacetylase (HDAC) that is involved in transcriptional regulation (18) . Like the other class I HDACs, HDAC3 requires recruitment to its cognate co-repressor protein (SMRT) to have full enzymatic activity (19) . HDACs are important therapeutic targets for the treatment of cancer (20) , and are involved in other diseases such as Alzheimer's and HIV (21) (22) . HDAC3 and its activation domain from the SMRT co-repressor (SMRT-DAD) do not interact when expressed in bacterial cells but require expression in higher eukaryotes to form a complex. The HDAC3:SMRT-DAD complex is phosphorylated in the C-terminal region of HDAC3 and also acetylated (as determined by mass spectrometry). The structure of the HDAC3:SMRT-DAD complex revealed the presence of an Ins(1,4,5,6)P4 molecule at the interface between HDAC3 and SMRT which is required for complex formation and activation (23).
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To show the benefit of using mammalian rather than bacterial cells to express human proteins, SAP and PKMζ were tested for expression in both E. coli and HEK 293 cells (24) (25) (26) . In Figure   1 it can be seen that SAP in a vector containing a signal sequence is expressed and secreted using HEK cells ( Figure 1 , lanes 1 and 2), but not in E. coli (lanes 3 and 4). Without the signal sequence, some SAP is accumulated in the cells using HEK cell expression (lane 6), but there is no expression in E. coli (lanes 7 and 8). The band in lane 6 migrates lower than those in lanes 1 and 2 as no post-translational modification has taken place. For PKMζ, expression can be seen in the cells and in the soluble extraction for both HEK cells and E. coli (lanes 9 to 12), however expression levels are higher using HEK cells (lanes 9 and 10).
Materials

2.1
Protein expression using HEK 293T cells 8
Methods
Protein expression using attached HEK 293T cells
Depending on the scale of expression required and the equipment available, methods for both T175 static flasks and roller bottles are described below.
3.1.1 Medium scale using T175 flasks 1. All cell manipulations are carried out in a Class 2 laminar flow hood.
2. Seed HEK 293T cells at 7.5 x 10 5 cells/ml in 5 ml so that the cells are ~80 % confluent after 24 hours. Make up to 45 ml with DMEM containing 2 % FCS, 1 x non-essential amino acids and 1 mM glutamine.
3. Incubate the cells at 37°C in a 5 % CO2/95 % air atmosphere for 24 hours.
4. Mix 87.5 µl plasmid DNA (See Note 2) with 2.6 ml of DMEM supplemented with 1 x non-essential amino acids and 1 mM glutamine.
5. In a separate vessel, mix 154 µl 1 mg/ml PEI with 2.6 ml of DMEM containing 1
x non-essential amino acids and 1 mM glutamine. Add this to the DNA cocktail made in step 4 and mix thoroughly.
6. Incubate at room temperature for 10 minutes (See Note 3). Centrifuge for a further 15 minutes at 6,000g and freeze the resulting pellet at -80°C.
Protein expression using suspension HEK 293F cells
Depending on the scale of expression required and the equipment available, methods for both 250 ml Erlenmeyer flasks and roller bottles are described below. For cotransfections of two or more plasmids, the total amount of DNA used must be as indicated in the protocols below.
3.2.1 Medium scale using 250 ml flasks 1. 250 ml flasks will support between 30 and 100 ml culture. For transfection volumes greater than 30 ml the protocol can be scaled accordingly.
2. All cell manipulations are carried out in a Class 2 laminar flow hood.
3. Seed cells at 3.5 x 10 5 cells/ml in to a 250 ml flask with a final volume of 30 ml.
4. Incubate flask at 37°C in a 5 % CO2/95 % air atmosphere with the bottle rotating at 120 rpm for 3 days until the cells reach a density of > 2 x 10 6 cells/ml.
5. Dilute 30 g plasmid DNA (total) (See Note 2) in 3 ml PBS and vortex briefly.
6. Add 120 L of 0.5 mg/ml PEI to the diluted DNA and vortex briefly.
7. Incubate at room temperature for 20 minutes. of culture. Roller bottles will support a minimum volume of 150 ml and a maximum volume of 300 ml, for volumes less than 300 ml the protocol can be scaled accordingly.
2. Seed cells at 3.5 x 10 5 cells/ml in to a roller bottle with a final volume of 300 ml.
3. Incubate the roller bottle at 37°C in a 5 % CO2/95 % air atmosphere with the vertically orientated bottle shaking at 120 rpm for 3 days until the cells reach a density of > 2 x 10 6 cells/ml.
4. Dilute 300 g plasmid DNA (total) (See Note 2) in 30 ml PBS and vortex briefly.
5. Add 1.2 ml of 0.5 mg/ml PEI to the diluted DNA and vortex briefly.
6. Incubate at room temperature for 20 minutes.
7. Add the PBS, DNA and PEI cocktail to 270 ml cells at 1 x 10 6 cells/ml final concentration.
8. If control of glycosylation is required, add 0.3 ml of 1 mg/ml kifunensine to each roller bottle (See Note 4).
9. Incubate the roller bottle at 37°C in a 5 % CO2/95 % air atmosphere for 48 hrs.
10. To harvest protein: centrifuge cells at 6,000g for 5 minutes. For intracellular protein retain cells and store at -80°C and for secreted protein retain supernatant and filter through a 0.22 µm bottle top filter before storing at 4°C.
3.3
Purification of secreted proteins using a His6 tag
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This protocol describes an automated method for purification of secreted proteins from large volumes of media using an Äkta Xpress system (GE Healthcare Life Sciences, UK).
However, the initial immobilised metal affinity chromatography (IMAC) purification step (described in section 3.3.2) can be disconnected from the size exclusion chromatography step and automated using other Äkta purification systems.
3.3.1 Automated protocol using the Äkta Xpress 6. Run the glycoprotein purification programme transcribed in Nettleship et al. (27) (See Note 8).
7. This programme will complete an automated IMAC purification followed by further purification by size exclusion chromatography giving protein with over 95 % purity (See Figure 2 ). 14 3.3.2 Description of IMAC purification for use with other systems 1. 50 ml of media is loaded through a 5 ml HisTrap FF column at 8 ml/min followed by 10 ml of Nickel Wash Buffer.
2.
Step 1 is then repeated until all the media has been loaded through the column.
This load/wash loop reduces the impact of IMAC incompatible components in the media as well as addressing pressure problems due to the viscosity of the mammalian culture medium particularly if it contains FCS.
3.
The column is then washed with 50 ml (10 x column volume) of Nickel Wash
Buffer before elution of the protein with 25 ml (5 x column volume) Nickel Elution Buffer collecting 2 ml fractions.
4.
The product can then be further purified using size exclusion chromatography.
Purification of intracellular protein using a 3xFLAG® tag
The protocol below describes a method of purification using the 3xFLAG® tag from a 1.2 l transfection. This can be scaled appropriately for larger scale expression. This protocol, including the buffers stated, was developed for the purification of 3xFLAG®-HDAC3:SMRT-DAD complex (See Note 9). The method given is manual; however various stages of the process may be automated using Äkta purification systems. After the initial Anti-FLAG® purification, a size exclusion column is used to further purify the protein (including removing the TEV protease). 
